A Chinese company says its vaccine will be ready by December—but it won’t be cheap

Sinopharm, a state-owned Chinese pharmaceutical company, says that its COVID-19 vaccine will reach market by December, but its likely price tag is much higher than any put forward for a coronavirus vaccine so far. “It is expected to cost a few hundred yuan for a shot, and for two shots it should be less than 1000 yuan ($145),” Sinopharm CEO Liu Jingzhen, told a Chinese newspaper this week. Liu said that the cost is “not very high,” but, in fact, it's significantly more expensive than the projected prices of its peers.